Stock listing
Sk Bioscience Co.,ltd.
Selected listing: 302440 · KRX · KRW · KR
Sk Bioscience Co.,ltd. (KRX:302440), Health Technology. Latest release Mar 18, 2026: SK bioscience Secures Funding to Advance RSV Preventive Antibody…
- Ticker
- KRX:302440
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
About Sk Bioscience Co.,ltd.
Sk Bioscience Co., Ltd. is a publicly traded company on the Korean market under the ticker 302440. Sk Bioscience focuses on biopharmaceuticals and is involved in the development and production of vaccines and other biologics.
Latest news from Sk Bioscience Co.,ltd.
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
March 18, 2026
SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
February 26, 2026
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 28, 2026
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 22, 2026
Research Sk Bioscience Co.,ltd.
Sk Bioscience Co.,ltd. company profile
View the public company page for Sk Bioscience Co.,ltd. on 6ix.
Sk Bioscience Co.,ltd. news
Read company news and market updates connected to Sk Bioscience Co.,ltd..
Sk Bioscience Co.,ltd. investor events
Find investor webinars, events, and replay context for Sk Bioscience Co.,ltd..